Clinical trials
Amblyopia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 2 |
| 2004 | 5 |
| 2005 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Recruiting | 14 |
| Terminated | 9 |
| Unknown status | 5 |
| Withdrawn | 4 |
| Suspended | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jaeb Center for Health Research | 23 |
| Retina Foundation of the Southwest | 6 |
| Alaska Blind Child Discovery | 5 |
| National Eye Institute (NEI) | 5 |
| Rebiscan, Inc. | 5 |
| Boston Children's Hospital | 3 |
| Luminopia | 3 |
| Salus University | 3 |
| Johns Hopkins University | 2 |
| Massachusetts Eye and Ear Infirmary | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amblyopia | 80 |
| Strabismus | 18 |
| Anisometropia | 6 |
| Refractive Errors | 5 |
| Ocular Motility Disorders | 3 |
| Vision Disorders | 3 |
| Hyperopia | 2 |
| Myopia | 2 |
| Nystagmus, Pathologic | 2 |
| Alzheimer Disease | 1 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.